Contractor
XLCARE PHARMACEUTICALS INC
- UEI
- MEAUS5WHBJJ7
- Parent UEI
- K7TKCHBK8K72
- Resolved by
- uei
- Confidence
- 1.000
Active from Sep 14, 2021 to Oct 16, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36F79726D0120 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | May 6, 2026 | — |
| 36E79723D0027 NEW AWARD FOR GABAPENTIN CAPSULES WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS NOVEMBER 11, 2023 THROUGH NOVEMBER 10, 2024 WITH FOUR ONE YEAR OPTIONS. | Department of Veterans Affairs | — | Aug 14, 2023 | — |
| 36E79725D0045 NEW AWARD FOR TOPIRAMATE TABLETS WITH XLCARE. ORDERING PERIOD IS OCT 31, 2025 TO OCT 30, 2026 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Jun 26, 2025 | — |
| 36E79724D0034 NEW AWARD FOR OXCARBAZEPINE WITH XLCARE PHARMACEUTICALS. PERIOD OF PERFORMANCE IS OCT 14, 2024 TO OCT 13, 2025 WITH FOUR ONE-YEAR OPTIONS | Department of Veterans Affairs | — | Aug 15, 2024 | — |
| 36E79721D0051 2 LINE ITEMS DUTASTERIDE CAPSULES. AWARDED FOR A BASE YEAR OF 12/23/2021 TO 12/22/2022 PLUS 4 ONE-YEAR OPTION PERIODS. | Department of Veterans Affairs | — | Sep 14, 2021 | — |
| 36E79726D0007 3 LINE ITEMS FOR MONTELUKAST 10MG TABLET. AWARDED FOR A BASE YEAR OF 5/10/2026 TO 5/9/2027 PLUS 4 ONE-YEAR OPTION PERIODS. | Department of Veterans Affairs | — | Jan 8, 2026 | — |
| 36E79725D0037 NEW AWARD FOR LOSARTAN TABLETS WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 9/24/2025-9/23/2026. | Department of Veterans Affairs | — | Jul 2, 2025 | — |
| 36E79725D0004 NEW AWARD FOR LEVOTHYROXINE NA TABLETS WITH XLCARE PHARMACEUTICALS, INC. BASE YEAR ORDERING PERIOD IS JAN 27, 2025 THROUGH JAN 26, 2026 WITH FOUR ONE-YEAR OPTIONS | Department of Veterans Affairs | — | Nov 27, 2024 | — |
| 36E79724D0018 AWARD TO XLCARE PHARMACEUTICALS FOR METHOCARBAMOL TABLETS FOR THE BASE YEAR WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Jan 24, 2024 | — |
| 36E79726D0027 NEW AWARD FOR CARBIDOPA/LEVODOPA IMMEDIATE-RELEASE (IR) TABLETS WITH XLCARE PHARMACEUTICALS, INC. ORDERING PERIOD IS JUNE 21, 2026 TO JUNE 20, 2027 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Mar 27, 2026 | — |
| 36E79726D0019 NEW AWARD FOR LEVETIRACETAM TABLETS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD FEB 5, 2026 TO MAY 23, 2026, WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Feb 5, 2026 | — |
| 36E79723D0018 NEW AWARD FOR LACOSAMIDE INJECTIONS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD IS MAY 13, 2023 TO MAY 12, 2024 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Mar 14, 2023 | — |
| 36E79726D0024 NEW AWARD FOR ALLOPURINOL TABLETS WITH XLCARE PHARMACEUTICALS, INC. ORDERING PERIOD IS MAY 30, 2026 TO MAY 29, 2027 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Mar 9, 2026 | — |
| 36E79722D0023 NEW AWARD FOR PANTOPRAZOLE TABLETS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD IS JUNE 26, 2022 TO JUNE 25, 2023 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Apr 27, 2022 | — |
| 36F79721D0091 TPR | Department of Veterans Affairs | — | Mar 4, 2026 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier MEAUS5WHBJJ7, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.